Klein Pavlis & Peasley Financial’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,017
Closed -$300K 90
2026
Q1
$300K Buy
1,017
+7
+0.7% +$2.08K 0.17% 82
2025
Q4
$276K Sell
1,010
-27
-3% -$7.34K 0.16% 85
2025
Q3
$280K Buy
1,037
+155
+18% +$42.2K 0.17% 83
2025
Q2
$243K Sell
882
-217
-20% -$59K 0.16% 69
2025
Q1
$288K Buy
1,099
+78
+8% +$19.2K 0.21% 68
2024
Q4
$237K Buy
1,021
+20
+2% +$4.6K 0.19% 74
2024
Q3
$221K Sell
1,001
-86
-8% -$17.8K 0.18% 74
2024
Q2
$214K Sell
1,087
-15
-1% -$3.1K 0.19% 75
2024
Q1
$237K Sell
1,102
-32
-3% -$6.72K 0.21% 68
2023
Q4
$239K Buy
+1,134
New +$242K 0.22% 71

Other funds holding CME

Klein Pavlis & Peasley Financial's CME Position: Q2 2026 in Review

Klein Pavlis & Peasley Financial sold out of CME Group (CME) in Q2 2026, closing a stake of 1,017 shares — an estimated $300K sold.

Klein Pavlis & Peasley Financial first reported a position in CME in Q4 2023 and held it in 10 quarters. The position peaked at $300K in Q1 2026. 599 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Klein Pavlis & Peasley Financial reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Klein Pavlis & Peasley Financial sold 1,017 CME Group shares in Q2 2026, an estimated $300K.
  • Klein Pavlis & Peasley Financial first reported a position in CME Group in Q4 2023 and held it in 10 quarters.
  • Klein Pavlis & Peasley Financial's CME Group position peaked at $300K in Q1 2026.
  • 599 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Klein Pavlis & Peasley Financial's 13F filing for Q2 2026, filed 23 Jul 2026.